BANK OF AMERICA CORP /DE/ - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 82 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,651,601
-25.4%
836,467
+16.9%
0.00%
Q2 2023$3,555,881
-30.2%
715,469
-30.6%
0.00%
-100.0%
Q1 2023$5,096,420
-6.3%
1,031,664
+19.3%
0.00%0.0%
Q4 2022$5,437,566
+38.4%
864,478
+137.7%
0.00%
Q3 2022$3,928,000
+28.6%
363,661
+35.7%
0.00%
Q2 2022$3,055,000
-42.2%
267,992
-53.8%
0.00%
-100.0%
Q1 2022$5,284,000
+31.3%
579,926
+115.1%
0.00%
Q4 2021$4,023,000
+170.5%
269,634
+366.0%
0.00%
Q3 2021$1,487,000
-65.0%
57,866
-64.5%
0.00%
Q2 2021$4,253,000
+104.5%
163,101
+176.8%
0.00%
Q1 2021$2,080,000
-75.7%
58,923
-82.6%
0.00%
-100.0%
Q4 2020$8,563,000
+428.6%
339,268
+689.6%
0.00%
Q3 2020$1,620,000
-21.9%
42,968
-11.4%
0.00%
Q2 2020$2,075,000
+267.3%
48,473
+66.6%
0.00%
Q1 2020$565,000
-23.6%
29,103
+2.1%
0.00%
Q4 2019$740,000
-27.6%
28,502
-24.0%
0.00%
Q3 2019$1,022,000
-46.4%
37,518
-47.1%
0.00%
Q2 2019$1,907,000
-30.5%
70,988
-25.2%
0.00%
Q1 2019$2,745,000
+398.2%
94,942
+364.7%
0.00%
Q4 2018$551,00020,4330.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$46,213,00013.24%
Wildcat Capital Management, LLC 1,716,370$44,111,0005.71%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$481,009,0004.77%
Copernicus Capital Management, LLC 15,000$386,0004.67%
Coastal Bridge Advisors, LLC 301,240$7,742,0001.79%
Lombard Odier Asset Management (Switzerland) SA 914,416$23,500,0001.46%
Casdin Capital, LLC 2,100,000$53,970,0001.34%
Pier Capital, LLC 450,182$11,570,0001.20%
Ghost Tree Capital, LLC 150,000$3,855,0001.13%
Sessa Capital IM, L.P. 750,000$19,275,0000.95%
View complete list of ALLOGENE THERAPEUTICS INC shareholders